218 related articles for article (PubMed ID: 10393456)
1. Multiple fixed drug eruption caused by iomeprol (Iomeron), a nonionic contrast medium.
Watanabe H; Sueki H; Nakada T; Akiyama M; Iijima M
Dermatology; 1999; 198(3):291-4. PubMed ID: 10393456
[TBL] [Abstract][Full Text] [Related]
2. Fixed drug eruption caused by iopamidol, a contrast medium.
Yamauchi R; Morita A; Tsuji T
J Dermatol; 1997 Apr; 24(4):243-5. PubMed ID: 9164065
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
Vijayalakshmi K; Kunadian B; Wright RA; Hall JA; Stewart MJ; Davies A; Sutton A; de Belder MA
Eur J Radiol; 2007 Feb; 61(2):342-50. PubMed ID: 17101256
[TBL] [Abstract][Full Text] [Related]
4. Drug eruption caused by nonionic iodinated X-ray contrast media.
Akiyama M; Nakada T; Sueki H; Fujisawa R; Iijima M
Acad Radiol; 1998 Apr; 5 Suppl 1():S159-61. PubMed ID: 9561070
[No Abstract] [Full Text] [Related]
5. Drug eruption caused by the nonionic contrast medium iohexol. "Recall-like phenomenon" appearing on an area previously affected by herpes zoster.
Matsumura T; Watanabe H; Batchelor J; Sueki H; Iijima M
J Dermatol; 2006 Oct; 33(10):705-8. PubMed ID: 17040501
[TBL] [Abstract][Full Text] [Related]
6. Fixed drug eruption induced by an iodinated non-ionic X-ray contrast medium: a practical approach to identify the causative agent and to prevent its recurrence.
Böhm I; Medina J; Prieto P; Block W; Schild HH
Eur Radiol; 2007 Feb; 17(2):485-9. PubMed ID: 16937101
[TBL] [Abstract][Full Text] [Related]
7. Acute localized exanthematous pustulosis (ALEP) induced by iomeprol (Iomeron 350): A diagnostic challenge.
Navarro Triviño FJ; Linares-González L; Ródenas-Herranz T; Llamas-Molina JM; Ruiz-Villaverde R
Contact Dermatitis; 2021 Jul; 85(1):95-97. PubMed ID: 33474760
[No Abstract] [Full Text] [Related]
8. Evaluation of the adverse effects of iomeprol.
Schmiedel E
Eur J Radiol; 1994 May; 18 Suppl 1():S104-8. PubMed ID: 8020511
[TBL] [Abstract][Full Text] [Related]
9. Non-immediate hypersensitivity reactions to iomeprol: Diagnostic value of skin tests and cross-reactivity with other iodinated contrast media.
Gamboa P; Sánchez de Vicente J; Galán C; Jáuregui I; Segurola A; García-Lirio E; Seras Y; Martínez-Antón MD; Arrien de Lecea A
Allergy; 2022 Dec; 77(12):3641-3647. PubMed ID: 35815908
[TBL] [Abstract][Full Text] [Related]
10. Pseudoephedrine may cause "pigmenting" fixed drug eruption.
Ozkaya E; Elinç-Aslan MS
Dermatitis; 2011 May; 22(3):E7-9. PubMed ID: 21569741
[TBL] [Abstract][Full Text] [Related]
11. Meprobamate-induced fixed drug eruption.
Zaïem A; Kaabi W; Badri T; Lakhoua G; Sahnoun R; Kastalli S; Daghfous R; Lakhal M; El Aidli S
Curr Drug Saf; 2014; 9(2):161-2. PubMed ID: 24446836
[TBL] [Abstract][Full Text] [Related]
12. Drug eruptions to contrast media in Japan.
Nakada T; Akiyama M; Iijima M; Kato A; Maibach HI
Clin Exp Dermatol; 2006 May; 31(3):361-4. PubMed ID: 16681576
[TBL] [Abstract][Full Text] [Related]
13. Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives.
Cravo M; Gonçalo M; Figueiredo A
Int J Dermatol; 2007 Jul; 46(7):760-2. PubMed ID: 17614812
[TBL] [Abstract][Full Text] [Related]
14. Non-pigmenting fixed drug eruption caused by allylisopropylacetylurea.
Numata Y; Terui T; Sasai S; Sugawara M; Kikuchi K; Tagami H; Aiba S
Contact Dermatitis; 2003 Oct; 49(4):175-9. PubMed ID: 14996063
[TBL] [Abstract][Full Text] [Related]
15. Fixed Drug Eruption due to Iopromide (Ultravist®).
Cha SH; Kim HS; Lee JY; Kim HO; Park YM
Ann Dermatol; 2011 Sep; 23 Suppl 1(Suppl 1):S33-5. PubMed ID: 22028567
[TBL] [Abstract][Full Text] [Related]
16. Fixed drug eruption associated with intravenous contrast media: report in a woman receiving iohexol.
Wright NA; Cohen PR
J Drugs Dermatol; 2011 Jul; 10(7):802-4. PubMed ID: 21720665
[TBL] [Abstract][Full Text] [Related]
17. [Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis].
Huynh VA; Lungoci E; Villani A; Ben Said B; Hacard F; Nicolas JF; Bérard F
Ann Dermatol Venereol; 2016 Dec; 143(12):852-855. PubMed ID: 27080820
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of drug eruption due to iohexol (Omnipaque)].
Akiyama M; Iijima M; Fujisawa R
Nihon Hifuka Gakkai Zasshi; 1990 Sep; 100(10):1057-60. PubMed ID: 1702479
[TBL] [Abstract][Full Text] [Related]
19. Delayed-type hypersensitivity to a nonionic, radiopaque contrast medium.
Courvoisier S; Bircher AJ
Allergy; 1998 Dec; 53(12):1221-4. PubMed ID: 9930602
[TBL] [Abstract][Full Text] [Related]
20. Etoricoxib-induced fixed drug eruption with positive lesional patch tests.
Calistru AM; Cunha AP; Nogueira A; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):154-6. PubMed ID: 21108578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
